Literature DB >> 18172064

Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation.

A H Rajput1, H H Sitte, A Rajput, M E Fenton, C Pifl, O Hornykiewicz.   

Abstract

BACKGROUND: Patients with Parkinson disease (PD) may be akinetic/rigid, be tremor dominant, or have comparable severity of these motor symptoms (classic). The pathophysiologic basis of different PD phenotypes is unknown. This study assessed pallidal and striatal dopamine level patterns in different motor subgroups of PD and normal control brains.
METHODS: Globus pallidus and striatum dopamine (DA) levels were measured with high performance liquid chromatography in eight autopsy confirmed PD and five control frozen brains.
RESULTS: DA levels in the external globus pallidus (GPe) of normal brains were nearly six times greater than in the internal pallidum (GPi). In PD, the mean loss of DA was marked (-82%) in GPe and moderate (-51%) in GPi. DA loss of variable degree was seen in different subdivisions of GPe and GPi in PD; however, DA levels were near normal in the ventral (rostral and caudal) GPi of PD cases with prominent tremor. There was marked loss of DA (-89%) in the caudate and severe loss (-98.4%) in the putamen in PD. The pattern of pallidal DA loss did not match the putaminal DA loss.
CONCLUSION: There is sufficient loss of dopamine (DA) in external globus pallidus and the internal globus pallidum (GPi) as may contribute to the motor manifestations of Parkinson disease (PD). The possible functional disequilibrium between GABAergic and DAergic influences in favor of DA in the caudoventral parts of the GPi may contribute to resting tremor in tremor dominant and classic PD cases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18172064     DOI: 10.1212/01.wnl.0000285082.18969.3a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  61 in total

1.  Blood oxygenation level-dependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's disease.

Authors:  Janey Prodoehl; Mathew Spraker; Daniel Corcos; Cynthia Comella; David Vaillancourt
Journal:  Mov Disord       Date:  2010-10-15       Impact factor: 10.338

Review 2.  The external globus pallidus: progress and perspectives.

Authors:  Daniel J Hegeman; Ellie S Hong; Vivian M Hernández; C Savio Chan
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

3.  Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease.

Authors:  Gaetano Barbagallo; Maria Eugenia Caligiuri; Gennarina Arabia; Andrea Cherubini; Angela Lupo; Rita Nisticò; Maria Salsone; Fabiana Novellino; Maurizio Morelli; Giuseppe Lucio Cascini; Domenico Galea; Aldo Quattrone
Journal:  Hum Brain Mapp       Date:  2017-06-20       Impact factor: 5.038

4.  Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.

Authors:  Jeffrey H Kordower; C Warren Olanow; Hemraj B Dodiya; Yaping Chu; Thomas G Beach; Charles H Adler; Glenda M Halliday; Raymond T Bartus
Journal:  Brain       Date:  2013-08       Impact factor: 13.501

5.  Relation of Parkinson's disease subtypes to visual activities of daily living.

Authors:  Daniel R Seichepine; Sandy Neargarder; Ivy N Miller; Tatiana M Riedel; Grover C Gilmore; Alice Cronin-Golomb
Journal:  J Int Neuropsychol Soc       Date:  2011-08-04       Impact factor: 2.892

Review 6.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

7.  Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease.

Authors:  Marcello Moccia; Sabina Pappatà; Marina Picillo; Roberto Erro; Anna Rita Daniela Coda; Katia Longo; Carmine Vitale; Marianna Amboni; Arturo Brunetti; Giuseppe Capo; Marco Salvatore; Paolo Barone; Maria Teresa Pellecchia
Journal:  J Neurol       Date:  2014-08-14       Impact factor: 4.849

8.  Side and type of initial motor symptom influences visuospatial functioning in Parkinson's disease.

Authors:  Daniel R Seichepine; Sandy Neargarder; Sigurros Davidsdottir; Gretchen O Reynolds; Alice Cronin-Golomb
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

Review 9.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

10.  Npas1+ Pallidal Neurons Target Striatal Projection Neurons.

Authors:  Kelly E Glajch; Daniel A Kelver; Daniel J Hegeman; Qiaoling Cui; Harry S Xenias; Elizabeth C Augustine; Vivian M Hernández; Neha Verma; Tina Y Huang; Minmin Luo; Nicholas J Justice; C Savio Chan
Journal:  J Neurosci       Date:  2016-05-18       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.